(firstQuint)LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients.

 The study is a 2-way crossover design comprising 2 treatments: the CE-marked LAMELLEYE dry eye drops, and a CE-marked comparator product.

 All Participants will be allocated to a treatment group in a random order.

 The study design allows observations to be made between the treatments at both an intra- and inter-patient level regarding relationships between the patient's disease specific quality of life, symptoms and adverse events, and satisfaction with treatments.

.

 LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients@highlight

Single-blind, randomised, single centre, 2-way crossover pilot study to investigate the effectiveness of LAMELLEYE for the treatment of dry eye symptoms in patients with primary Sjogren's Syndrome.

